Related Experiment Video
Updated: Nov 3, 2025
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Loss of Gas7 Is a Key Metastatic Switch in Neuroblastoma
1Department of Neurology, University of California, San Francisco, San Francisco, California. marie.menard@ucsf.edu.
Abstract:
Metastatic spread to distant tissues and organs is responsible for most cancer-related mortalities. Changes in the invasiveness ability of metastatic tumor cells often come with significantly altered gene expression profiles compared with primary tumor cells. Identifying the main actors involved in the metastatic switch of tumor cells is key to proposed new therapeutic approaches. In this issue, the loss of growth-arrest specific 7 is described as one of the main events driving metastatic spread in neuroblastoma.See related article by Dong et al., p. 2995.
Insights
The loss of growth-arrest specific 7 (GAS7) is a key driver of metastatic spread in neuroblastoma. Understanding GAS7
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Metastatic spread is the primary cause of cancer mortality.
- Tumor cell invasiveness is linked to altered gene expression.
- Identifying key regulators of metastasis is crucial for new therapies.
Purpose of the Study:
- To identify key molecular events driving metastatic spread in neuroblastoma.
- To investigate the role of growth-arrest specific 7 (GAS7) in neuroblastoma metastasis.
Main Methods:
- Analysis of gene expression profiles in primary versus metastatic neuroblastoma cells.
- Functional studies to assess the impact of GAS7 loss on tumor cell invasiveness.
Main Results:
- Significant alterations in gene expression profiles distinguish metastatic from primary neuroblastoma cells.
- Loss of growth-arrest specific 7 (GAS7) is identified as a critical event in promoting neuroblastoma metastasis.
Conclusions:
- Growth-arrest specific 7 (GAS7) plays a significant role in the metastatic progression of neuroblastoma.
- Targeting GAS7 may offer a novel therapeutic strategy for neuroblastoma.
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...